Focus: Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
'Food controlled me and my GP dismissed it so I turned to weight loss jab Mounjaro'
Lana Hart, 29, has given a searingly honest account about why she turned to weight loss injection Mounjaro amid a national ...
National clampdown on weight loss jabs like Wegovy amid fears Brits are abusing them
General Pharmaceutical Council issues new guidance following reports people are lying about their weight in online forms and submitting photos of themselves in baggy clothes ...
Hosted on MSN19h
Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock?
Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...
Canadian Cancer Society’s volunteer driver program helps people get to treatment appointments
The Canadian Cancer Society’s Wheels of Hope transportation program, provides rides to and from treatment appointments for ...